Delivery Order SPE2DX22D0019-SPE2D826FAA19
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,036.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 26, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price contract, classified as a non-set-aside competitive award, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- On October 24, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,768.00 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, with an ultimate completion date of October 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,449.06 to AmerisourceBergen Drug Corp (CAGE: 0U9U0) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to be delivered to the Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp serves as a critical vendor...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,666.17 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply delivery to support federal healthcare requirements. The contract is performed from AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $1,651.68 to AmerisourceBergen Drug Corp on October 23, 2025, with an ultimate completion date of October 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,119.35 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 16, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply procurement. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $139,894.92 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $27,272.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 2, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The company's place of performance...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D826FAA19Delivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,699.83 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 1, 2025. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime contractor on this order, which represents a child contract under a larger federal contract vehicle. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA contracts with AmerisourceBergen Drug Corp to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems requiring flexible and comprehensive pharmaceutical supply capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/1/25 |